EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications

Guodong Yu, Weiying Ge, Hongliang Yao, Xuefeng Bai, Jianfei Wu, Yuan Wang, Jiangtao Bai, Yong Cui, Jijing Han

Oncology Research · 2026 · 34 (7) · 1-10

DOI: 10.32604/or.2026.080746 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Guodong Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBiomarkers, TumorHumansMetabolic ReprogrammingTumor MicroenvironmentAnimals

Stichwörter der Autor:innen

Metabolic reprogrammingbiomarkershepatocellular carcinomaimmune checkpointtumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding, China.
  • Department of Radiology, Affiliated Hospital of Hebei University, Baoding, China.
  • The Second Department of general surgery, Hengshui people's Hospital, Hengshui, China.
  • Department of Interventional and Vascular Surgery, Affiliated Hospital of Hebei University, Baoding, China.
  • Department of Pediatrics, Affiliated Hospital of Hebei University, Baoding, China.

Zitieren

APA

Yu, G., Ge, W., Yao, H., Bai, X., Wu, J., Wang, Y., Bai, J., Cui, Y., & Han, J. (2026). Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications. Oncology Research, 34(7), 1-10. https://doi.org/10.32604/or.2026.080746

Vancouver

Yu G, Ge W, Yao H, Bai X, Wu J, Wang Y, et al. Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications. Oncology Research. 2026;34(7):1-10. doi:10.32604/or.2026.080746

BibTeX
@article{Yu2026,
  author = {Yu, Guodong and Ge, Weiying and Yao, Hongliang and Bai, Xuefeng and Wu, Jianfei and Wang, Yuan and Bai, Jiangtao and Cui, Yong and Han, Jijing},
  title = {Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {7},
  pages = {1--10},
  doi = {10.32604/or.2026.080746}
}
Kostenlos starten →